Top Markets
#1 Helium Helium +77.57%
#2 Seeker Seeker +40.20%
#3 Pons Pons +33.69%
#4 UnifAI Network UnifAI Network +29.61%
#5 TENDIES TENDIES +26.41%
#6 Zylo Ecosystem Zylo Ecosystem +21.90%
#7 Tensor Tensor +21.88%
#8 pipedog pipedog +17.97%
#9 Bounce Bounce +16.14%
#10 Songbird Songbird +15.40%
Coin of the day
Helium Helium
設定
言語
日本
通貨
USD
テーマ
Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Ltd.

SENORES
株式のランク #11030
Established in 2017 and headquartered in Ahmedabad, India, Senores... Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.
株価
$16.36
最終同期: 2026-08-28
時価総額
$753.27M
変化（1日）
0.51%
変化（1年）
108.95%
国
IN
取引 Senores Pharmaceuticals Ltd. (SENORES)

カテゴリー

Healthcare
Senores Pharmaceuticals Ltd.（SENORES）の収益
Aug 2026 時点の収益 TTM: 0
Senores Pharmaceuticals Ltd. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Senores Pharmaceuticals Ltd. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B -
US